Edition:
United Kingdom

Foamix Pharmaceuticals Ltd (FOMX.OQ)

FOMX.OQ on NASDAQ Stock Exchange Global Market

6.08USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$6.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
28,309
52-wk High
$10.29
52-wk Low
$4.03

Latest Key Developments (Source: Significant Developments)

Foamix Q2 loss per share $0.27
Wednesday, 10 Aug 2016 

Foamix Pharmaceuticals Ltd : Q2 loss per share $0.27 . Q2 earnings per share view $-0.25 -- Thomson Reuters I/B/E/S . Foamix reports second quarter 2016 financial results and provides business update .Q2 revenue $752,000 versus $109,000.  Full Article

Foamix names Dr Stanley Hirsch chairman, and Dr Dalia Megiddo member of board
Monday, 16 May 2016 

Foamix Pharmaceuticals Ltd : Hirsch replaces meir eini, who is retiring from board but will continue as co's chief innovation officer .Foamix names dr. Stanley hirsch as chairman, and dr. Dalia megiddo as a member of the board of foamix pharmaceuticals.  Full Article

Foamix reports Q1 loss per share $0.15
Tuesday, 10 May 2016 

Foamix Pharmaceuticals Ltd : Foamix reports first quarter 2016 financial results and provides business update . Q1 loss per share $0.15 .Q1 revenue $745,000 versus $448,000.  Full Article

BRIEF-Tamarkin Medical Reports 7.3 Percent Passive Stake In Foamix Pharmaceuticals

* TAMARKIN MEDICAL INNOVATIONS LTD REPORTS 7.3 PERCENT PASSIVE STAKE IN FOAMIX PHARMACEUTICALS AS OF DECEMBER 31, 2017 - SEC FILING Source text: (http://bit.ly/2so9g8s) Further company coverage: